Clinical trial of KX2 391 for skin disorders.

Trial Profile

Clinical trial of KX2 391 for skin disorders.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 15 Dec 2015

At a glance

  • Drugs KX 01 (Primary)
  • Indications Psoriasis; Skin disorders
  • Focus Adverse reactions
  • Sponsors PharmaEssentia Corporation
  • Most Recent Events

    • 15 Dec 2015 Status changed from planning to recruiting, as per Athenex media release.
    • 05 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top